Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Ocular Therapeutix Inc. buy Piper Sandler

Start price
€9.41
26.02.24 / 50%
Target price
€13.83
26.02.25
Performance (%)
-52.84%
Price
€4.44
26.04.24
Summary
This prediction is currently active. Massive losses of -52.84% have been the result for the BUY prediction by Piper_Sandler. This prediction currently runs until 26.02.25. The prediction end date can be changed by Piper_Sandler at any time. Piper_Sandler has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Ocular Therapeutix Inc. -9.397% -9.397%
iShares Core DAX® 2.594% -1.158%
iShares Nasdaq 100 3.553% -1.727%
iShares Nikkei 225® 0.687% -8.354%
iShares S&P 500 2.209% -0.942%

Comments by Piper_Sandler for this prediction

In the thread Ocular Therapeutix Inc. diskutieren
Prediction Buy
Perf. (%) -52.84%
Target price 13.832
Change
Ends at 26.02.25

Ocular Therapeutix, Inc. (NASDAQ: OCUL) had its price target raised by analysts at Piper Sandler from $10.00 to $15.00. They now have an "overweight" rating on the stock.
Ratings data for OCUL provided by MarketBeat